Fiber and Insulin Sensitivity by Kevin, C. Maki & Tia, M. Rains
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
9 
Fiber and Insulin Sensitivity 
Kevin C. Maki and Tia M. Rains 
Provident Clinical Research, Biofortis North America 
United States of America 
1. Introduction 
The prevalence of type 2 diabetes mellitus (T2DM) continues to increase at an alarming rate. 
Approximately 18.8 million people in the United States have diagnosed diabetes, whereas 
7.0 million people are estimated to be living with the disease undiagnosed (Centers for 
Disease Control and Prevention [CDC], 2011). Another 79 million adults 20 years and older 
have pre-diabetes: impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) 
(CDC, 2011). Approximately 20-30% of individuals with pre-diabetes progress to T2DM 
within 3-4 years (DeFronzo et al., 2011; Knowler et al., 2002). 
The progression from normal glucose tolerance to the onset of T2DM is protracted and 
preceded by metabolic abnormalities that ultimately lead to hyperglycemia. Early in the 
disease process, individuals typically exhibit resistance to insulin-stimulated glucose uptake 
at the cellular level (Reaven et al., 2005). Insulin resistance is also associated with a cluster of 
metabolic disorders including central obesity, dyslipidemia and hypertension that are risk 
factors for T2DM and atherosclerotic cardiovascular disease (Alexander et al., 2000). The 
aggregation of these disorders is often referred to as metabolic syndrome or cardiometabolic 
syndrome (Reaven et al., 2005).  
Insulin resistance manifests as decreased insulin-stimulated glucose uptake at adipose and 
skeletal muscle tissues, as well as impaired suppression of hepatic glucose output by a given 
circulating level of insulin (DeFronzo, 2009; Goldstein 2003). Normal glucose tolerance is 
maintained via compensatory hyperinsulinemia, thus preventing hyperglycemia in the 
earliest stages (Reaven et al., 2005).  Over time, the pancreatic beta-cell response becomes 
inadequate to maintain normoglycemia, and hyperglycemia ensues. It is unclear whether 
there is an exhaustion of the beta-cells, or if the beta-cells become progressively less 
responsive to the changes in circulating glucose, or a combination of these defects (Ferannini 
et al., 2005; Butler et al., 2003; Khan, 2001). Regardless, progressive beta-cell dysfunction 
ultimately leads to an inability to secrete sufficient insulin to maintain normoglycemia after 
a carbohydrate load. In frank T2DM, insulin secretion becomes sufficiently impaired to 
result in hyperglycemia in the fasting state (Stolar, 2010). By the time T2DM is diagnosed, 
the insulin secretory response is generally 70-80% below that which would be appropriate 
for the prevailing level of insulin resistance (Ferannini et al., 2005; Maki et al., 2009). The 
interplay between insulin resistance and beta-cell dysfunction in the development of T2DM 
(DeFronzo, 2009; Khan 2001) and methods of assessing insulin sensitivity in clinical research 
(Muniyappa et al., 2008; Singh 2010) have been reviewed in detail elsewhere. 
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2. Dietary patterns and diabetes risk 
Diabetes prevention trials have shown that interventions which increase insulin sensitivity 
significantly reduce the rate of conversion to diabetes in high risk individuals (Knowler et 
al., 2002; Tuomilehto et al., 2001; Lindstrom et al., 2003; Pan et al., 1997; Zinman et al., 2010; 
DeFronzo et al., 2011). In the Diabetes Prevention Program, a lifestyle intervention with 
targets of 150 minutes per week of moderate intensity physical activity and weight loss of 
7% reduced the rate of progression to diabetes by 58% relative to a group that received 
placebo without lifestyle intervention (Knowler et al., 2002), which was greater than the 31% 
reduction in new-onset diabetes with metformin treatment. Other lifestyle intervention 
studies of weight loss and enhanced physical activity have shown reductions in the 
incidence of new-onset type 2 diabetes of 25-60% over 3-6 year timeframes in individuals 
with pre-diabetes (Lindstrom et al., 2003; Pan et al., 1997). Both weight loss and increased 
physical activity enhance insulin sensitivity, which results in a reduced requirement for 
insulin secretion, thus “unloading” the beta-cells. In turn, this may extend the time during 
which the available insulin secretory response can maintain normoglycemia. In addition, 
there is evidence that some interventions that improve insulin sensitivity may arrest, or 
even partially reverse, the progression of beta-cell dysfunction (Utzschneider et al., 2008; 
Gastaldelli et al., 2007). 
Although weight loss and increased physical activity have received the most attention, 
particularly in clinical intervention trials, a number of other lifestyle factors may have 
important influences on the risk for T2DM. Dietary patterns characterized by high intakes of 
fruits and vegetables, whole grains, low-fat dairy products, and a low glycemic load have 
been inversely associated with T2DM risk (Figure). In contrast, dietary patterns 
characterized by high intakes of processed meats, refined grains, and foods containing high   
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Fig. Relative risks for the associations between cereal fiber, fruit fiber, and vegetable fiber 
with risk of type 2 diabetes mellitus. Adapted from Schulze et al. 2007. CI = confidence 
interval.  
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amounts of added sugars have been associated with increased T2DM risk (Heidemann et al., 
2005; Montonen et al., 2005; Fung et al., 2007; Gittelsohn et al., 1998; van Dam et al., 2002; 
Hodge et al., 2007; Montonen et al., 2005; Brunner et al., 2008; Williams et al., 2000). In 
particular, an inverse association with T2DM risk has been identified for higher consumption 
of whole-grain foods (Liu et al., 2000; Murtaugh et al, 2003). Prospective studies have shown 
that consumption of approximately 3 servings per day of whole grain foods is associated with 
a reduced risk for T2DM by 20-30% versus consumption of <3 servings of whole grain foods 
per week (de Munter et al., 2007; Kastorini & Panagiotakos, 2009). 
Whole grains contain a number of constituents that may influence T2DM risk, including 
fibers, vitamins, minerals, lignans, and phytochemicals. The focus of this review is on the 
potential influences of dietary fibers on risk for T2DM, and the mechanisms that may 
account for these associations. Nevertheless, the reader should keep in mind that dietary 
fiber intake correlates with a number of other dietary and lifestyle factors that may influence 
risk for T2DM, thus fiber intake is likely only one component of the apparent protective 
effect of a low-risk eating pattern. 
3. Intakes of dietary fibers and risk for T2DM 
Greater consumption of dietary fiber is associated with lower risk for the development of 
T2DM, and this may explain, at least in part, the relationship between consumption of 
whole grains and diabetes risk (Björck& Elmståhl, 2003). Previously, it was thought the 
reduction in risk might be attributable to the consumption of viscous soluble fibers such as 
beta-glucan, psyllium, and pectin. Such fibers form viscous solutions when mixed with fluid 
in the gastrointestinal (GI) tract, creating a physical barrier to digestive enzymes and 
through which simple sugars must travel to reach the intestinal brush border for absorption 
(Dikeman & Fahey, 2006; Wolever, 1991; Jenkins et al., 1978). As such, postprandial glucose 
responses are attenuated when viscous fibers are consumed as part of carbohydrate-rich 
meals, effectively lowering the glycemic index of such foods (Jenkins et al., 2000, Maki et al., 
2007). Prospective epidemiological and observational studies have shown associations 
between intakes of high-glycemic index foods and high-glycemic load diets and a greater 
risk of T2DM, consistent with this potential mechanism (Biesalski 2004, Salmeron et al., 
1997a, 1997b). 
However, results from prospective cohort studies have shown that consumption of 
insoluble cereal fibers is more strongly inversely associated with risk of T2DM than 
consumption of soluble fibers (McKeown et al., 2004; Schulze et al., 2007; Weickert & 
Pfeiffer, 2008). For example, in a cohort of ~25,000 men and women ages 35 to 65 years, 
greater intake of cereal fibers, but not fruit or vegetable fibers, was inversely associated with 
developing diabetes over an 11 year period after adjusting for lifestyle and dietary 
confounders (Schulze et al., 2007). Similarly, a meta-analysis of nine cohort studies on fiber 
also showed an inverse association for cereal fiber and T2DM risk, but not other fibers 
(Schulze et al., 2007). Most sources of dietary fiber contain both soluble and insoluble fiber 
in varying amounts, but whole grain products generally contain a high proportion of 
insoluble cereal fiber (Weickert & Pfeiffer, 2008; McKee & Latner, 2000). In the U.S. diet, the 
main sources of soluble fiber are fruits and vegetables, and to a smaller extent, oats and 
barley (McKee & Latner, 2000). 
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4. Dietary fiber, colonic fermentation and T2DM risk 
Results from several recent studies suggest that fermentability may be a more important 
factor in the association between dietary fiber intake and T2DM risk than solubility or 
viscosity. In particular, there is accumulating evidence for a metabolic link between 
consumption of fibers which are fermented in the lower intestine and insulin sensitivity. 
This relationship appears likely to be mediated, at least in part, by the inverse association 
between short chain fatty acid (SCFA) and free fatty acid (FFA) levels in circulation 
(Robertson et al, 2003, 2005).  
Elevated levels of circulating FFA are associated with insulin resistance and it is thought 
that they contribute to reduced insulin action in the skeletal muscle and liver (Kim et al, 
2007). FFA disrupt glucose metabolism by enhancing beta-oxidation in peripheral tissues 
and by competing with glucose for oxidation, resulting in a reduction of peripheral glucose 
uptake (Tarini & Wolever, 2010). Sustained elevation of FFA, induced through intravenous 
infusion of a lipid emulsion, down regulates glycogen storage and leads to a reduction of 
non-oxidative glucose disposal, thus reducing insulin sensitivity (Ferrannini et al., 1983; 
Kashyap et al., 2003; Homko et al., 2003). Potential mechanisms by which FFA might affect 
glycogen regulation include increased expression and activation of glucose-6-phosphatase 
(Clore et al., 2000; Van de Werve et al., 2000). Conversely, suppression of FFA levels with an 
infusion of acipimox, a niacin derivative that inhibits hormone sensitive lipase, improves 
glucose tolerance and peripheral insulin sensitivity (Ferrannini et al., 1983). 
The release of FFA shows diurnal variation and is correlated with hepatic glucose output 
during sleep (Morgan et al., 1999, Kim et al., 2007). In normal weight individuals the fall of 
hepatic glucose output during sleep is highly synchronized with a decrease in FFA levels 
(Clore et al., 1989). Conversely, T2DM subjects have an increased rate of FFA appearance at 
night and elevated plasma FFA levels that are correlated with increased overnight hepatic 
glucose output (Miles et al., 2003; Taskinen et al., 1989). This increase in FFA levels and 
release of insulin can be acutely reduced with a pharmacological block of lipoloysis, 
suggesting that a reduction in FFA release may lead to improved glucose homeostasis 
(Andreotti et al., 1994). In the canine model of moderate obesity, an increase in nocturnal 
FFA levels and reduced insulin sensitivity occurred after 6 weeks of high-fat feeding, 
despite no changes in fasting FFA, fasting glucose or postprandial glucose levels, providing 
further support that the overnight period may be particularly important (Kim et al., 2007). 
Given the known diurnal fluctuations of FFA observed in overweight and obese subjects, 
and in the moderately obese canine model, it is likely that the nocturnal increase in FFA is a 
key factor in the development of insulin resistance and may play a significant role in the risk 
for T2DM. 
Consumption of indigestible fibers provides available substrate for resident microbiota in 
the large intestine, which form fermentation products, particularly SCFA (acetate, butyrate, 
and propionate). Upon absorption into the circulation, SCFA suppress the release of FFA 
from adipose tissue, thus lowering the concentrations of FFA in circulation, which, in turn, 
could lead to improved insulin sensitivity and concomitant reduced risk for T2DM (Tarini & 
Wolever, 1991).  
Feeding studies in humans support this proposed relationship between colonic fermentation 
and peripheral metabolic effects (Table). Nilsson et al. (2008) provided healthy subjects 
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evening meals containing a variety of cereal-based foods with varying levels of resistant 
starch and fermentable fiber. They demonstrated a relationship between colonic 
fermentation, as measured by breath hydrogen, and glucose tolerance at the subsequent 
breakfast meal more than nine hours later (Nilsson et al., 2008). Compared to white bread in 
the evening, consumption of bread made with barley kernels, high beta-glucan barley, or 
white bread supplemented with resistant starch and barley fiber all reduced the 
postprandial curves for glucose and insulin after a subsequent standard breakfast, 
consistent with improved insulin sensitivity. Additionally, the glucose response was 
inversely associated with SCFA concentrations (butyrate and acetate) and was positively 
correlated with FFA during the postprandial period. 
Several studies have demonstrated enhanced insulin sensitivity, measured with the 
euglycemic clamp (the reference standard method) or other methods, after consumption of 
fermentable fibers or resistant starches over periods ranging from several hours to several 
weeks (Landin et al., 1988; Robertson et al., 2003, 2005; Maki et al., 2011). Landin et al. (1988) 
showed improved insulin sensitivity in healthy, nonobese men measured by euglycemic-
clamp following intake of 30 g/d guar gum. More recently, Robertson et al (2003) examined 
the role of resistant starch (RS) on insulin sensitivity in healthy subjects following a 60 g 
load of RS consumed over the course of one day. Increased insulin sensitivity was positively 
associated with fasting breath hydrogen levels and lower FFA levels in the late postprandial 
period (Robertson et al., 2003). In a subsequent study comparing 30 g RS/day for four weeks 
versus a control starch, insulin sensitivity during a meal tolerance test was 33% higher and 
glucose clearance adjusted for insulin concentration was 44% higher following RS intake 
compared with the control condition. Insulin sensitivity, as measured by the euglycemic-
hyperinsulinemic clamp, was also higher following RS (Robertson et al., 2005). In a chronic 
(12-week) study in insulin resistant subjects, 40 g RS/day (supplied in sachets to mix into 
their daily foods) was associated with improved insulin sensitivity compared to placebo 
(Johnston et al., 2010). Insulin sensitivity was also correlated with changes in waist 
circumference, however there was no difference in body mass index, total adipose tissue 
content or regional distribution between the groups suggesting the observed improvement 
in insulin sensitivity is not directly attributable to changes in body composition (Johnston et 
al., 2010). In a study of overweight and obese subjects with normal glucose metabolism, 
Weikert et al. (2006) reported a 13% improvement in insulin sensitivity in subjects who 
consumed white bread supplemented with 31.2 g/d insoluble fiber fraction from oat fiber 
over 72 hours, compared to a white bread control. 
Not all studies have shown favorable effects of fermentable fibers on insulin sensitivity. 
Ebeling et al. (1988) studied the effects of 5 g/d guar gum for 4 weeks in individuals with 
type 1 diabetes mellitus and showed that guar gum lowered the postprandial glucose 
response and reduced insulin requirements, suggesting an improvement in hepatic insulin 
sensitivity. However, there was no measurable effect on peripheral insulin sensitivity, as 
measured by euglycemic insulin clamp. Given that this study was small (n = 9), a type II 
error (lack of power) cannot be ruled out. A study in 21 men with metabolic syndrome also 
failed to show differences in insulin sensitivity measured by euglycemic insulin clamp 
following a 5-week dietary intervention with 28 g/day of acacia gum and pectin (Pouteau et 
al., 2010).  
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Authors Study Population Design Study Products Results 
Andersson 
et al., 2007 
Healthy volunteers 
(n=30) 
Age (y): 59+5  
BMI (kg/m2):  
28.3+2.0  
Randomized 
crossover 6-
week study of 
diet rich in 
whole grains 
vs. diet 
containing 
equal amount 
of refined grain
 
 Whole grain diet 
contained 112 g/d 
of whole grain, 18 
g fiber 
 Refined grain diet 
contained 6 g/d 
fiber 
 
No effect of whole 
grains on insulin 
sensitivity 
Ebeling et 
al., 1988 
Type 1 diabetics 
(n=9) 
Age (y): 27+2 
Body Weight (kg): 
71+3 
 
Double-blind 
crossover with 
two 4-week 
study periods 
 5 g/d granulated 
guar 
 
 Control- 0 g/d 
No effect on 
insulin sensitivity 
Johnston et 
al., 2010 
Insulin resistant 
subjects (n=20) 
Age (y):      
 Resistant starch- 
45.2+3.55 
 BMI (kg/m2):  
 Resistant starch- 
31.3+1.70 
 Placebo- 
30.4+1.15 
 
Single-blind, 
randomized, 
parallel 12-
week 
intervention 
 Resistant starch 
supplement -40 
g/d 
 
 Control- 0 g/d 
Improved insulin 
sensitivity with 
resistant starch 
 
Landin et 
al., 1992 
Healthy, nonobese 
middle –aged men 
(n=25) 
Age (y): 52.0+5.2 
BMI (kg/m2): 
24.6+1.6 
Double-blind 
placebo-
controlled, 
cross-over with 
two 6-week 
interventions 
 30 g/d granulated 
guar, given in 3-10 
g doses 
 30 g/d granulated 
gelling starch 
(control), given in 
3-10 g doses 
 
Improved insulin 
sensitivity with 
guar diet 
 
Maki et al., 
2011 
Healthy subjects 
with increased 
waist 
circumference (n = 
33) 
Age (y): 49.5 ± 1.6 
BMI (kg/m2 ): 30.6 
± 0.5 
Double-blind 
crossover with 
two 4-week 
interventions. 
 High-resistant 
starch diet- 30 g/d 
 Low-resistant 
starch diet- 15 g/d 
 Control- 0 g/d  
Improved  
insulin sensitivity 
with both  
resistant starch 
diets, but effect 
only reached 
statistical 
significance for 
men. 
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Authors Study Population Design Study Products Results 
 
Nilsson et 
al., 2008 
 
Healthy volunteers  
(n=15) 
Age (y): 25.9+3.2 
BMI (kg/m2 ):  
22.5+2.1  
 
Crossover of 
cereal-based 
evening test 
meals with 
varying GI and 
amount of 
resistant starch
 
Cereal-based meals: 
 
 White bread 
(control) 
 White bread 
enriched with 
barley fiber and 8 
g resistant starch 
 Barley kernel 
based bread 
 
Improved glucose 
tolerance with 
resistant starch 
Pouteau et 
al., 2010 
Men with 
metabolic 
syndrome (n=21) 
Age (y): 47+12 
BMI (kg/m2): 
33.4+3.0 
Double-blind 
crossover with 
two 5-week 
interventions. 
Beverages: 
 28 g/d acetogenic 
fibers (acacia gum 
and pectin)  
 Control  
No effect on 
insulin sensitivity 
Robertson et 
al., 2003 
Healthy subjects 
(n=10) 
Age (y): 23-65 
BMI: (kg/m2):  
20.3-35.9 
Single-blind 
crossover with 
two 24-hour 
interventions 
 High-resistant 
starch diet- 60 g/d 
 Low-resistant 
starch diet- 0 g/d  
Improved insulin 
sensitivity with 
resistant starch. 
Robertson et 
al., 2005 
Healthy subjects 
(n=10) 
Age (y):  
48.5+3.4 
BMI (kg/ m2):  
23.4+1.4
Single-blind, 
crossover with 
two 4-week 
interventions 
 Resistant starch 
diet-30 g /d 
 Control-0 g/d  
Improved insulin 
sensitivity with 
resistant starch. 
Weickert et 
al., 2006 
Overweight and 
obese subjects with 
normal glucose 
metabolism (n=17) 
Age (y): 52.9+8.7 
BMI (kg/ m2):  
30.4+2.0 
Single-blind 
crossover with 
two 72-hour 
interventions 
Macronutrient-
matched breads 
 
 Fiber-enriched 
with 31.2 g 
insoluble fiber 
 Control (white 
bread) 
Improved insulin 
sensitivity with 
increased 
insoluble fiber  
 
Table: Clinical trials on the effects of fermentable fibers on insulin sensitivity 
5. Conclusion 
A dietary pattern characterized by high intakes of whole grains, fruits and vegetables, low-
fat dairy products, and a low glycemic load has been associated with lower T2DM risk. 
Whole grains possess a number of constituents that may influence T2DM risk, including 
vitamins, minerals, lignans and phytochemicals. Greater dietary fiber intake is also 
associated with lower risk for the development of T2DM, and this may explain, at least in 
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part, the relationship between consumption of whole grains and reduced diabetes risk. 
Results from recent intervention studies suggest that fermentability may be the key 
characteristic of fibers associated with improved insulin sensitivity, providing a metabolic 
link between dietary fiber intake and reduction in T2DM risk. Future studies on the 
relationships between dietary fiber, production of SCFAs, circulating FFA release, and 
physiological mediators such as incretins (glucagon-like peptide-1 and glucose-dependent 
insulinotropic polypeptide), and inflammatory markers (e.g., interleukin-6, adiponectin), are 
warranted. There is also a need for longer-term intervention trials to determine the 
mechanisms by which dietary fibers, particularly fermentable fibers, influence health and 
T2DM risk. 
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